Metadata
Author: EMEA0.3
Data
Bulgarian[bg]
Рисперидон показва статистически значима и клинично важна ефективност при лечението на агресия и по-малък ефект при лечението на възбудата и тревогата при пациенти в старческа възраст с деменция (според оценката за патология на поведението в оценъчната скала за болестта на Алцхаймер [ BEHAVE-AD ] и в скалата на Cohen-Mansfield за възбуда [ CMAI ]
Danish[da]
Risperidon viste statistisk signifikant og klinisk betydningsfuld effekt til behandling af aggression og mindre entydig effekt til behandling af agitation og psykose hos ældre demente patienter (målt på BEHAVE-AD-skalaen (Behavioural Pathology in Alzheimer' s Disease Rating Scale) og CMAI-skalaen (Cohen-Mansfield Agitation Inventory
Greek[el]
Η αποτελεσματικότητα της ρισπεριδόνης δείχθηκε ότι είναι στατιστικά και κλινικά σημαντική στη θεραπεία της επιθετικότητας και λιγότερο συνεπής στη θεραπεία της διέγερσης και της ψύχωσης σε ηλικιωμένους ασθενείς με άνοια (όπως μετρείται από την Κλίμακα Behavioural Pathology in Alzheimer’ s Disease [ BEHAVE-AD ]) και Cohen-Mansfield Agitation Inventory
English[en]
Risperidone showed statistically significant and clinically important effectiveness in treating aggression and less consistently in treating agitation and psychosis in elderly dementia patients (as measured by the Behavioural Pathology in Alzheimer s Disease Rating Scale [ BEHAVE-AD ] and the Cohen-Mansfield Agitation Inventory [ CMAI ]
Estonian[et]
Risperidoon oli statistiliselt oluliselt ja ka kliiniliselt tõhusam agressiooni ravis ja vähem tõhus agitatsiooni ja psühhoosiga eakate dementsete patsientide ravis (hinnatuna Behavioural Pathology in Alzheimer’ s Disease Rating Scale [ BEHAVE-AD ] ja Cohen-Mansfield Agitation Inventory [ CMAI ] alusel
French[fr]
La rispéridone a montré une efficacité statistiquement et cliniquement supérieure dans le traitement de l agressivité, et à un moindre degré de l agitation et de la psychose chez des patients âgés déments (tels que mesurée par la Behavioural Pathology in Alzheimer s Disease Rating Scale BEHAVE-AD [ BEHAVE-AD ] et au Cohen-Mansfield Agitation Inventory [ CMAI ]
Hungarian[hu]
A riszperidon statisztikailag szignifikáns és klinikailag jelentős hatékonyságot mutatott az idős, demens betegek agressziójának kezelésében valamint kevésbé következetes hatékonyságot agitációjuk és pszichózisuk kezelésében (a Behavioural Pathology in Alzheimer’ s Disease Rating Scale [ BEHAVE-AD ] és a Cohen-Mansfield Agitation Inventory [ CMAI ] skálákon mérve
Italian[it]
Risperidone ha evidenziato un efficacia terapeutica statisticamente significativa e clinicamente importante nel trattare l aggressione e meno consistente per l agitazione e la psicosi dei pazienti anziani con demenza (come misurato dalla scala Behavioural Pathology in Alzheimer s Disease [ BEHAVE-AD-] e dalla Cohen Mansfield Agitation Inventory [ CMAI ]
Latvian[lv]
Risperidonam tika konstatēta statistiski nozīmīga un klīniski svarīga efektivitāte agresivitātes ārstēšanā un mazāk konsekventa efektivitāte uzbudinājuma un psihozes ārstēšanā gados vecākiem demences slimniekiem (nosakot pēc Izturēšanās patoloģijas Alcheimera slimības gadījumā vērtēšanas skalas (Behavioural Pathology in Alzheimer’ s Disease Rating Scale; BEHAVE-AD) un Koena-Mansfīlda Uzbudinājuma aptaujas anketas (Cohen-Mansfield Agitation Inventory; CMAI
Polish[pl]
Stwierdzono statystycznie istotną i klinicznie znaczącą skuteczność rysperydonu w leczeniu agresji, i mniej zaznaczoną w leczeniu pobudzenia i psychozy u starszych pacjentów z demencją (wg pomiarów w skali Behavioural Pathology In Alzheimer’ s Disease Rating Scale [ BEGAVE-AD ] i Cohen-Mansfield Agitation Inventory [ CMAI ]
Portuguese[pt]
A risperidona demonstrou eficácia estatisticamente significativa e clinicamente importante no tratamento da agressividade e demonstrou ser menos consistente no tratamento da agitação e psicose em doentes idosos com demência (medido pela escala Behavioural Pathology in Alzheimer ́s Rating Scale (BEHAVE-AD) e pela escala Cohen-Mansfield Agitation Inventory (CMAI
Romanian[ro]
Risperidona a demonstrat eficacitate semnificativă statistic şi importantă clinic în tratarea agresiunii şi mai puţină consistenţă în tratarea agitaţiei şi psihozei la pacienţii vârstnici cu demenţă (conform măsurătorilor de Patologie comportamentală pe scala de punctare a bolii Alzheimer [ BEHAVE-AD ] şi Evaluarea agitaţiei Cohen-Mansfield [ CMAI ]
Slovak[sk]
Risperidón preukázal u starších pacientov s demenciou štatisticky významnú a klinicky dôležitú účinnosť v liečbe agresivity a menšiu účinnosť v liečbe agitácie a psychózy (meranie podľa škály BEHAVE-AD [ Behavioural Pathology in Alzheimer’ s Disease Rating Scale ] a CMAI [ Cohen-Mansfield Agitation Inventory ]
Slovenian[sl]
Risperidon je bil statistično značilno boljši in klinično pomembnejši pri zdravljenju agresije, in manj uspešen pri zdravljenju agitacije in psihoze pri starejših bolnikih z demenco (merjeno po BEHAVE-AD (Behavioural Pathology in Alzheimer’ s Disease) in CMAI (Cohen-Mansfield Agitation Inventory lestvici
Swedish[sv]
Risperidon uppvisade statistiskt signifikant och kliniskt betydelsefull effekt vid behandling av aggressivitet, och mindre tydliga resultat vid behandling av agitation och psykos hos äldre patienter med demens (utifrån resultat på BEHAVE-AD-skalan [ Behavioural Pathology in Alzheimer’ s Disease Rating Scale ] och CMAI-inventoriet [ Cohen-Mansfield Agitation Inventory ]